uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted March 30, 2015

FDA Finds Problems at 62% of Supplement Manufacturing Sites in U.S. and Abroad has obtained results of the FDA's inspections in 2014 of 483 dietary supplement manufacturing facilities, showing that most -- 62% -- received letters indicating noncompliance with current Good Manufacturing Practices (cGMPs). Manufacturers are required by law to follow cGMPs, but only a small fraction of facilities are inspected by the FDA each year. The results, by manufacturer, are posted on the website (member sign-in required) and include results for manufacturers in the U.S. and abroad, listed by country. Manufacturers which passed inspection without a citation are highlighted in green, while those receiving a letter of noncompliance, known as a Form FDA 483, are highlighted in red.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at